We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Rogue Blood Cells Contribute to Postsurgery Organ Damage

By HospiMedica International staff writers
Posted on 07 Jul 2011
A new study sheds light on how rogue super-activated neutrophils reenter the blood stream, causing damage to organs seemingly unconnected to the surgical injury.

Researchers at Queen Mary University of London (United Kingdom) used real-time three-dimensional (3D) confocal imaging to examine the polarized transendothelial migration (TEM) of blood neutrophils through endothelial cells (ECs) lining the venular lumen. More...
While TEM is usually in a luminal-to-abluminal direction, the researchers found that neutrophils also had disrupted polarized TEM--either hesitant or even reversed--in inflammation after ischemia-reperfusion injury.

These reverse direction migrations were characterized by lower expression of junctional adhesion molecule C (JAM-C) at EC junctions. When the researchers temporarily blocked the blood vessels, mimicking the trauma experienced by patients undergoing major surgery, JAM-C was lost from the blood vessels. When this happened, the neutrophils seemed to lose their way. Cells that had already exited blood vessels returned to the blood stream and damaged other parts of the body. In particular, the researchers found that these confused but highly activated neutrophils lodged into blood vessels in the lungs, causing damage.

According to the researchers, the JAM-C molecule and the properties of these rogue neutrophils could lead to the development of drugs aimed at reducing life-threatening complications following major surgeries such as inflammation of the lungs. The study was published early online on June 26, 2011, in Nature Immunology.

“Neutrophils are usually our first line of defense against infection but they have the ability to cause many diseases. As we learn more about the complex processes that protect us against infections we also find ways of tackling inflammatory diseases where white blood cells are inappropriately switched on,” said lead author Prof. Sussan Nourshargh, PhD. “The neutrophils that behave this way are very different from normal blood neutrophils in that they are highly activated and fully capable of causing damage to other organs.”

Related Links:
Queen Mary University of London



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.